Director
National Cancer Center Research Institute, Japan
Dr. Hiroyuki Mano graduated from School of Medicine, The University of Tokyo in 1984. He then joined The Third Department of Internal Medicine, Faculty of Medicine, The University of Tokyo in 1986, and majored in clinical hematology. Dr. Mano became Professor at Division of Functional Genomics, Jichi Medical University in 2011, and then became Professor at Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo in 2013. Dr. Mano was also appointed to the Director of Research Institute, National Cancer Center in 2016, and also has been the Director of Cancer Genomics and Advanced Therapeutics, National Cancer Center since 2018. He is also a member of The Japan Academy since 2021. Because of the discovery of many oncogenes such as EML4-ALK, Dr. Mano received numerous prestigious awards including The Medal of Honor with Purple Ribbon from The Japanese Emperor (2012), The Japan Academy Prize from The Japan Academy (2021), The Léopold Griffuel Award from Fondation ARC, France (2021) and The Asahi Prize from the Asahi Shinbun Foundation (2023).
